LIVE FROM THE DATABASETRANSACTIONS 362,430COMPANIES 5,763LATEST TRADE Oct 16UPDATED Oct 17, 12:31 AM
JBIOCIK 0001798749

Jade Biosciences, Inc.

14 transactions by 10 insiders, from February 12, 2026 to June 25, 2026.

Transactions
1410 insiders
Bought · P
Nonenobody bought on the open market
Sold · S
Nonenobody sold on the open market
Net
+$0net buying

Officers and directors

People inside the company. What they do with their own shares is the reason this data exists.

InsiderTradesPlannedBoughtSold
Andrew James KingOfficer2———
Tom FrohlichCEO2———
Bradford D. DahmsCFO2———
Elizabeth BaltaOfficer2———
Eric DobmeierDir1———
Mark EisnerDir1———
Christopher W. CainDir1———
Erin LavelleDir1———
Lawrence Otto KleinDir1———
Fairmount Funds Management LLCDir1———

All transactions

14 in total, newest filings first.

InsiderDateCodeSharesPriceValue
Mark EisnerDirDERIVJun 25A47,675$0.00—?
Lawrence Otto KleinDirDERIVJun 9A34,843$0.00—?
Erin LavelleDirDERIVJun 9A34,843$0.00—?
Fairmount Funds Management LLCDirDERIVJOINTJun 9A34,843$0.00—?
Eric DobmeierDirDERIVJun 9A34,843$0.00—?
Christopher W. CainDirDERIVJun 9A34,843$0.00—?
Andrew James KingOfficerDERIVFeb 12A247,500$0.00—?
Andrew James KingOfficerFeb 12A41,250$0.00—
Tom FrohlichCEODERIVFeb 12A472,500$0.00—?
Tom FrohlichCEOFeb 12A78,750$0.00—
Bradford D. DahmsCFODERIVFeb 12A226,875$0.00—?
Bradford D. DahmsCFOFeb 12A37,813$0.00—
Elizabeth BaltaOfficerDERIVFeb 12A168,750$0.00—?
Elizabeth BaltaOfficerFeb 12A28,125$0.00—